3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
11
Pain, Postoperative
10
Agnosia
6
Stomach Neoplasms
4
Prostatic Neoplasms
4
Pain
4
Lung Neoplasms
4
Neoplasms
3
Postoperative Complications
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Supratentorial Neoplasms
1
Sleep Deprivation
1
Sarcoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Neuroblastoma
1
Neoplasm Metastasis
1
Meningioma
1
Malignant Neoplasms of Male Genital Organs
1
Leiomyoma
1
Intraoperative Complications
1
Goiter
1
Ganglion Cysts
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Emergence Delirium
1
Interventions
Gemcitabine
74
Capecitabine
60
Paclitaxel
59
Fluorouracil
58
Oxaliplatin
57
Bevacizumab
51
Docetaxel
50
Leucovorin
48
Nivolumab
40
Cisplatin
40
Irinotecan
39
Carboplatin
37
Cetuximab
34
pembrolizumab
32
Radiosurgery
32
Trastuzumab
30
Radiotherapy
27
Everolimus
24
Sorafenib
23
Pemetrexed
20
Doxorubicin
20
Albumin-Bound Paclitaxel
20
Ipilimumab
19
Cyclophosphamide
19
Panitumumab
18
Zoledronic Acid
17
Lapatinib
17
Erlotinib Hydrochloride
17
Prednisone
16
pazopanib
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasm Metastasis
×
Ropivacaine
×
Clear all
NCT01194843
2015-04-21
DPO
Centre Leon Berard
Phase NA
Completed
85 enrolled